再鼎醫藥(09688)全年度虧損收窄至3.35億美元 X
28/02/2024 07:46
<匯港通訊>      再鼎醫藥有限公司(09688)公布截至2023年12月31日止全年度業績:

股東應佔虧損: 3.35億美元, 虧損收窄 (去年同期虧損4.43億美元)
每股虧損: 0.35美元


(ST)



Infocast Limited and its information providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.